| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
10,245 |
8,604 |
$1.50M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,666 |
5,706 |
$462K |
| 87481 |
|
7,174 |
6,124 |
$398K |
| 87640 |
|
9,293 |
7,950 |
$116K |
| 87500 |
|
7,082 |
6,056 |
$92K |
| 87653 |
|
7,096 |
6,065 |
$91K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,335 |
3,756 |
$90K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,193 |
1,960 |
$66K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
577 |
503 |
$55K |
| 87634 |
|
2,078 |
1,872 |
$48K |
| 87641 |
|
4,068 |
3,489 |
$46K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,392 |
2,108 |
$43K |
| 87486 |
|
2,706 |
2,379 |
$37K |
| 87581 |
|
2,702 |
2,375 |
$36K |
| 87541 |
|
2,577 |
2,282 |
$35K |
| 87498 |
|
2,193 |
1,960 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
597 |
534 |
$16K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
284 |
201 |
$14K |
| 87631 |
|
284 |
266 |
$13K |
| 81230 |
|
65 |
65 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
245 |
219 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
248 |
221 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
245 |
219 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$2K |
| 81225 |
|
22 |
22 |
$1K |
| 87186 |
|
17 |
16 |
$971.12 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
101 |
84 |
$956.99 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
54 |
52 |
$836.59 |
| 80053 |
Comprehensive metabolic panel |
65 |
58 |
$729.50 |
| 81003 |
|
327 |
291 |
$435.88 |
| 81226 |
|
25 |
22 |
$356.50 |
| 81328 |
|
58 |
58 |
$233.74 |
| 87070 |
|
13 |
12 |
$231.38 |
| 87077 |
|
17 |
16 |
$191.04 |
| 80061 |
Lipid panel |
13 |
12 |
$182.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
16 |
$63.60 |
| 0002A |
|
53 |
35 |
$56.78 |
| 81291 |
|
22 |
22 |
$52.40 |
| 0001A |
|
51 |
33 |
$16.94 |
| 36415 |
Collection of venous blood by venipuncture |
993 |
742 |
$2.51 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
29 |
26 |
$0.00 |
| 81241 |
|
21 |
21 |
$0.00 |
| 81401 |
|
31 |
29 |
$0.00 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
599 |
450 |
$0.00 |
| 81231 |
|
63 |
63 |
$0.00 |
| 81240 |
|
21 |
21 |
$0.00 |